The neurobiology of gliomas: from cell biology to the development of therapeutic approaches (Q37910730)

25 August 2017

1 reference

title

The neurobiology of gliomas: from cell biology to the development of therapeutic approaches (English)

1 reference

25 August 2017

1 reference

1 reference

Manfred Westphal

1

1 reference

PubMed ID

21811295

25 August 2017

Katrin Lamszus

series ordinal

2

1 reference

PubMed ID

21811295

25 August 2017

language of work or name

English

0 references

publication date

3 August 2011

1 reference

Nature Reviews Neuroscience

25 August 2017

1 reference

25 August 2017

12

1 reference

25 August 2017

9

1 reference

25 August 2017

495-508

1 reference

https://scigraph.springernature.com/pub.10.1038/nrn3060

25 August 2017

0 references

cites work

Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.

1 reference

The 2007 WHO classification of tumours of the central nervous system

31 March 2020

1 reference

Molecular neuropathology of gliomas

31 March 2020

1 reference

Molecular pathology of malignant gliomas

31 March 2020

1 reference

Molecular diagnostics of brain tumors

31 March 2020

1 reference

Glial Cells Generate Neurons—Master Control within CNS Regions: Developmental Perspectives on Neural Stem Cells

31 March 2020

1 reference

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

31 March 2020

1 reference

An integrated genomic analysis of human glioblastoma multiforme

31 March 2020

1 reference

IDH1 and IDH2 mutations in gliomas

31 March 2020

1 reference

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

31 March 2020

1 reference

The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations

31 March 2020

1 reference

Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism

31 March 2020

1 reference

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

31 March 2020

1 reference

DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma

31 March 2020

1 reference

Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes

31 March 2020

1 reference

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

31 March 2020

1 reference

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

31 March 2020

1 reference

Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype

31 March 2020

1 reference

A multigene predictor of outcome in glioblastoma.

31 March 2020

1 reference

GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes

31 March 2020

1 reference

Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme

31 March 2020

1 reference

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.

31 March 2020

1 reference

Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma

31 March 2020

1 reference

Tumorigenesis in the brain: location, location, location.

31 March 2020

1 reference

Cell migration in the normal and pathological postnatal mammalian brain

31 March 2020

1 reference

Patterns and dynamics of SVZ cell migration in the postnatal forebrain: monitoring living progenitors in slice preparations.

31 March 2020

1 reference

Central nervous system neuronal migration

31 March 2020

1 reference

Multiple cell populations in the early postnatal subventricular zone take distinct migratory pathways: a dynamic study of glial and neuronal progenitor migration.

31 March 2020

1 reference

Control of astrocyte migration in the developing cerebral cortex.

31 March 2020

1 reference

How widespread is adult neurogenesis in mammals?

31 March 2020

1 reference

Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain.

31 March 2020

1 reference

The interface between glial progenitors and gliomas

31 March 2020

1 reference

The origins of glioma: E Pluribus Unum?

31 March 2020

1 reference

Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy

31 March 2020

1 reference

Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains.

31 March 2020

1 reference

Notch signalling regulates stem cell numbers in vitro and in vivo

31 March 2020

1 reference

Notch signaling in the mammalian central nervous system: insights from mouse mutants

31 March 2020

1 reference

HES and HERP families: multiple effectors of the Notch signaling pathway

31 March 2020

1 reference

Regulation of neural progenitor cell development in the nervous system

31 March 2020

1 reference

The Notch pathway mediates expansion of a progenitor pool and neuronal differentiation in adult neural progenitor cells after stroke

31 March 2020

1 reference

Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke

31 March 2020

1 reference

Vascular niche factor PEDF modulates Notch-dependent stemness in the adult subependymal zone

31 March 2020

1 reference

Identification of Nepro, a gene required for the maintenance of neocortex neural progenitor cells downstream of Notch

31 March 2020

1 reference

The functional role of Notch signaling in human gliomas

31 March 2020

1 reference

Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.

31 March 2020

1 reference

Notch, neural stem cells, and brain tumors.

31 March 2020

1 reference

The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo

31 March 2020

1 reference

Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.

31 March 2020

1 reference

The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas

31 March 2020

1 reference

γ-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells

31 March 2020

1 reference

Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors

31 March 2020

1 reference

NOTCH signaling as a novel cancer therapeutic target

31 March 2020

1 reference

The molecular logic of Notch signaling--a structural and biochemical perspective.

31 March 2020

1 reference

More complicated than it looks: assembly of Notch pathway transcription complexes

31 March 2020

1 reference

Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence

31 March 2020

1 reference

Targeting Notch to target cancer stem cells.

31 March 2020

1 reference

Cancer stem cells in nervous system tumors

31 March 2020

1 reference

The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases

31 March 2020

1 reference

CNS stem cells express a new class of intermediate filament protein

31 March 2020

1 reference

Sox-2 is expressed by neural progenitors and astroglia in the adult rat brain

31 March 2020

1 reference

Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell.

31 March 2020

1 reference

Identification of human brain tumour initiating cells

31 March 2020

1 reference

CD133 is a marker of bioenergetic stress in human glioma

31 March 2020

1 reference

Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.

31 March 2020

1 reference

Limits of CD133 as a marker of glioma self-renewing cells.

31 March 2020

1 reference

Neurosphere formation is an independent predictor of clinical outcome in malignant glioma

31 March 2020

1 reference

Glioblastoma formation from cell population depleted of Prominin1-expressing cells

31 March 2020

1 reference

A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

31 March 2020

1 reference

Epigenetic mechanisms in glioblastoma multiforme

31 March 2020

1 reference

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

31 March 2020

1 reference

Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation

31 March 2020

1 reference

MGMT gene silencing and benefit from temozolomide in glioblastoma

31 March 2020

1 reference

A microarray-based DNA methylation study of glioblastoma multiforme

31 March 2020

1 reference

Polycomb group protein-mediated repression of transcription

31 March 2020

1 reference

Expression of GATA6 in the human and mouse central nervous system

31 March 2020

1 reference

GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model

31 March 2020

1 reference

The transcriptional network for mesenchymal transformation of brain tumours.

31 March 2020

1 reference

Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.

31 March 2020

1 reference

Automated network analysis identifies core pathways in glioblastoma

31 March 2020

1 reference

Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines

31 March 2020

1 reference

Molecular mechanisms of glioma invasiveness: the role of proteases

31 March 2020

1 reference

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.

31 March 2020

1 reference

Diffuse "fibrillary" astrocytomas: correlation of MRI features with histopathologic parameters and tumor grade.

31 March 2020

1 reference

Topographic anatomy and CT correlations in the untreated glioblastoma multiforme.

31 March 2020

1 reference

Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations

31 March 2020

1 reference

Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes

31 March 2020

1 reference

Issues and progress with protein kinase inhibitors for cancer treatment

31 March 2020

1 reference

A survey of glioblastoma genomic amplifications and deletions

31 March 2020

1 reference

PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling

31 March 2020

1 reference

Modeling Adult Gliomas Using RCAS/t-va Technology

31 March 2020

1 reference

Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model

31 March 2020

1 reference

Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma

31 March 2020

1 reference

Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system

31 March 2020

1 reference

Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice

31 March 2020

1 reference

Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma

31 March 2020

1 reference

Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum

31 March 2020

1 reference

GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma

31 March 2020

1 reference

Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model

31 March 2020

1 reference

Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studies.

31 March 2020

1 reference

Subventricular zone astrocytes are neural stem cells in the adult mammalian brain

31 March 2020

1 reference

Olig gene function in CNS development and disease

31 March 2020

1 reference

A drosophila model for EGFR-Ras and PI3K-dependent human glioma

31 March 2020

1 reference

Modeling glioma growth and invasion in Drosophila melanogaster

31 March 2020

1 reference

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

31 March 2020

1 reference

Flies as the ointment: Drosophila modeling to enhance drug discovery

31 March 2020

1 reference

Genome-wide analysis of self-renewal in Drosophila neural stem cells by transgenic RNAi.

31 March 2020

1 reference

Molecular dissection of reactive astrogliosis and glial scar formation

31 March 2020

1 reference

Reactive astrogliosis induces astrocytic differentiation of adult neural stem/progenitor cells in vitro.

31 March 2020

1 reference

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

31 March 2020

1 reference

Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain

31 March 2020

1 reference

Stem cells as vehicles for the treatment of brain cancer

31 March 2020

1 reference

Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival.

31 March 2020

1 reference

Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells.

31 March 2020

1 reference

The antitumorigenic response of neural precursors depends on subventricular proliferation and age.

31 March 2020

1 reference

Stem and progenitor cell-mediated tumor selective gene therapy

31 March 2020

1 reference

Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas.

31 March 2020

1 reference

Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone

31 March 2020

1 reference

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

31 March 2020

1 reference

A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells

31 March 2020

1 reference

Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy

31 March 2020

1 reference

Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma

31 March 2020

1 reference

Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats

31 March 2020

1 reference

Combating immunosuppression in glioma

31 March 2020

1 reference

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

31 March 2020

1 reference

Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies

31 March 2020

1 reference

Applications of neural and mesenchymal stem cells in the treatment of gliomas

31 March 2020

1 reference

Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines.

31 March 2020

1 reference

Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains

31 March 2020

1 reference

Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation

31 March 2020

1 reference

Microglia in brain tumors

31 March 2020

1 reference

Relationship of lymphocyte invasion and survival of brain tumor patients

31 March 2020

1 reference

The brain tumor microenvironment.

31 March 2020

1 reference

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

31 March 2020

1 reference

Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy

31 March 2020

1 reference

Regulatory networks define phenotypic classes of human stem cell lines

31 March 2020

1 reference

Targeted therapy for malignant glioma patients: lessons learned and the road ahead

31 March 2020

1 reference

Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas

31 March 2020

1 reference

Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials

31 March 2020

1 reference

Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts

31 March 2020

1 reference

Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note.

31 March 2020

1 reference

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group

31 March 2020

1 reference

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas

31 March 2020

1 reference

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malig

31 March 2020

1 reference

Future of convection-enhanced delivery in the treatment of brain tumors.

31 March 2020

1 reference

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

31 March 2020

1 reference

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

31 March 2020

1 reference

Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2.

31 March 2020

1 reference

Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth

31 March 2020

1 reference

The evolution and application of techniques in molecular biology to human brain tumors: a 25 year perspective.

31 March 2020

1 reference

miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells

31 March 2020

1 reference

The evolution of our understanding on glioma

31 March 2020

1 reference

NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts

31 March 2020

1 reference

12 December 2020

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

1 reference

12 December 2020

1 reference

12 December 2020

Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain

1 reference

12 December 2020

Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.

1 reference

12 December 2020

Reaction of oligodendrocytes and astrocytes to trauma and implantation. A combined autoradiographic and immunohistochemical study.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRN3060

1 reference

25 August 2017

1 reference

PubMed ID

21811295